Deep Lens

Stale historical data is often only the best guess on broad I/E criteria. However, because our Real-Time Feasibility Dashboard integrates EMR and geometric data, we can give you up to date insights on your target patients. Learn more here: https://bit.ly/3yBuWgj

The goal of precision medicine is simply to deliver the right cancer treatment to the right patient at the right time. Oncology is the one therapeutic area that strongly supports this goal.

As more cellular treatments become FDA-approved, the need for established cellular therapy programs in the community setting will be crucial to expanding the availability of these novel treatments to patients. Learn more...

Are Cell and Gene Therapy Programs Primed for Community Oncology? Deep Lens' Director of Provider Network Amy Zuchelkowski shares her perspective on bringing cell and gene therapies to community oncology practices.

Are Cell and Gene Therapy Programs Primed for Community Oncology?

Offering cell-based therapy is uncharted territory for many community oncology practices. The treatments are seen as groundbreaking, and many patients desire access. Clinical trials allow for this access to the latest and greatest therapies in addition to close monitoring of care by the entire research team.


https://bit.ly/3N08Idi

"With the addition of automated molecular-based patient matching, we see VIPER giving us much greater granularity into how we work with our provider sites to drive greater patient engagement." - James Langford, AVITA Biomedical.

https://bit.ly/3xk8vf2

Does your clinical research department perform site audits or take other measures to ensure the quality of data submitted with a new drug application (NDA)?

On the Importance of Self-Audits in Clinical Research Deep Lens' Director of Provider Network Amy Zuchelkowski shares her perspective on preparing for FDA audits through diligence in reporting and record keeping.

Most clinical trial research sites under enroll patients. Our Real Time Feasibility Dashboard enables you to discover the best sites to activate for your trials: https://bit.ly/3xO4T6i

Stale historical data is often only the best guess on broad I/E criteria. However, because our Real-Time Feasibility Dashboard integrates EMR and geometric data, we can give you up to date insights on your target patients. Learn more here: https://bit.ly/3Hl16k6

Our team is loving . It's great to be together talking about clinical trial matching in person.

📌 Meet the Deep Lens team at the 2022 ASCO Annual Meeting on June 3 - 7, 2022, the most significant oncology research gathering of the year.

Learn more about the Annual Meeting, attendance registration, and the innovative technology which Deep Lens use to help support the diversity in the clinical research here https://bit.ly/3wFkkx9

Good Morning SCRS Diversity! Stay tuned with us to know more about oncology clinical research solutions and many inspiring successful stories!

We will be here tomorrow at Hilton Austin, the 2022 Global Oncology Site Solutions Summit venue. Meet us there and contact us for a meetup! https://bit.ly/3wa2bYg

# AI

identifies and matches patients to precision trials in the narrow window of opportunity through lab-agnostic genomic data ingestion.
Download our brochure to learn more about VIPER technology presented by . 👉https://bit.ly/3NemtoS

1 Week to go... Have you registered?
Let us know if you will be at the SCRS Diversity Site Solutions Summit on May 20, 2022, and the 2022 Global Oncology Site Solutions Summit in Austin, Texas, on May 21 and 22, 2022.

Contact us for a meetup; let’s work together for better clinical research solutions!

Know more about the summit and the technology which Deep Lens uses to help support the diversity in the clinical research here https://bit.ly/39lcBLH

# AI